Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma

Enhancer of Zeste homolog 2 (EZH2) is a critical component of the polycomb‐repressive complex 2 (PRC2) that regulates many essential biological processes, including embryogenesis and many developmental events. The oncogenic role of EZH2 has recently been implicated in several cancer types. In this s...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular carcinogenesis 2013-03, Vol.52 (3), p.229-236
Hauptverfasser: Wang, Cheng, Liu, Xiqiang, Chen, Zujian, Huang, Hongzhang, Jin, Yi, Kolokythas, Antonia, Wang, Anxun, Dai, Yang, Wong, David T.W., Zhou, Xiaofeng
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 236
container_issue 3
container_start_page 229
container_title Molecular carcinogenesis
container_volume 52
creator Wang, Cheng
Liu, Xiqiang
Chen, Zujian
Huang, Hongzhang
Jin, Yi
Kolokythas, Antonia
Wang, Anxun
Dai, Yang
Wong, David T.W.
Zhou, Xiaofeng
description Enhancer of Zeste homolog 2 (EZH2) is a critical component of the polycomb‐repressive complex 2 (PRC2) that regulates many essential biological processes, including embryogenesis and many developmental events. The oncogenic role of EZH2 has recently been implicated in several cancer types. In this study, we first confirmed that the over‐expression of EZH2 is a frequent event in oral tongue squamous cell carcinoma (OTSCC). We further demonstrated that EZH2 over‐expression is correlated with advanced stages of the disease and is associated with lymph node metastasis. Statistical analysis revealed that EZH2 over‐expression was correlated with reduced overall survival. Furthermore, over‐expression of EZH2 was correlated with reduced expression of tumor suppressor gene E‐cadherin. These observations were confirmed in vitro, in which knockdown of EZH2‐induced E‐cadherin expression and reduced cell migration and invasion. In contrast, ectopic transfection of EZH2 led to reduced E‐cadherin expression and enhanced cell migration and invasion. Furthermore, EZH2 may act on cell migration in part by suppressing the E‐cadherin expression. Taken together, these data suggest that EZH2 plays major roles in the progression of OTSCC, and may serve as a biomarker or therapeutic target for patients at risk of metastasis. © 2011 Wiley Periodicals, Inc.
doi_str_mv 10.1002/mc.21848
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3400713</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3095379751</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5428-98f91772c7ea09c4c9282010b5c8d1921c6073a17576bdf94a0fed7701ece66a3</originalsourceid><addsrcrecordid>eNp1kV1rFDEYhYModlsFf4EEvOnN1CSTmSQ3gixrW_qhgiJ4E7KZd7apk8k0mbHuvzfbbrcqCIFcvA8P53AQekXJESWEvfX2iFHJ5RM0o0TJggnOn6IZkUoVVEmxh_ZTuiaEUlGR52iPMVrTzMzQ9Cl0axv8Eq9imAY8xDCC6_Hi-wkrPDTOjNDgRWFNcwUxHyIMEVJyod-wPtMJexhNys8lHFocounwGPrVBDjdTMaHKWELXYetidb1wZsX6FlrugQvt_8B-vph8WV-Upx_PD6dvz8vbMWZLJRsFRWCWQGGKMutYpIRSpaVlQ1VjNqaiNLkUqJeNq3ihrTQCEEoWKhrUx6gd_feYVrmMhb6MYfTQ3TexLUOxum_L7270qvwU5ecEEHLLDjcCmK4mSCN2ru06WJ6yLU0ZZIzRVi1Qd_8g16HKfa5nqac51lUrcSj0MaQUoR2F4YSvdlSe6vvtszo6z_D78CH8TJQ3AO3roP1f0X6Yv4g3PIujfBrx5v4Q9eiFJX-dnms5dnF55qdVZqVvwFHOLgg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1441099697</pqid></control><display><type>article</type><title>Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Wang, Cheng ; Liu, Xiqiang ; Chen, Zujian ; Huang, Hongzhang ; Jin, Yi ; Kolokythas, Antonia ; Wang, Anxun ; Dai, Yang ; Wong, David T.W. ; Zhou, Xiaofeng</creator><creatorcontrib>Wang, Cheng ; Liu, Xiqiang ; Chen, Zujian ; Huang, Hongzhang ; Jin, Yi ; Kolokythas, Antonia ; Wang, Anxun ; Dai, Yang ; Wong, David T.W. ; Zhou, Xiaofeng</creatorcontrib><description>Enhancer of Zeste homolog 2 (EZH2) is a critical component of the polycomb‐repressive complex 2 (PRC2) that regulates many essential biological processes, including embryogenesis and many developmental events. The oncogenic role of EZH2 has recently been implicated in several cancer types. In this study, we first confirmed that the over‐expression of EZH2 is a frequent event in oral tongue squamous cell carcinoma (OTSCC). We further demonstrated that EZH2 over‐expression is correlated with advanced stages of the disease and is associated with lymph node metastasis. Statistical analysis revealed that EZH2 over‐expression was correlated with reduced overall survival. Furthermore, over‐expression of EZH2 was correlated with reduced expression of tumor suppressor gene E‐cadherin. These observations were confirmed in vitro, in which knockdown of EZH2‐induced E‐cadherin expression and reduced cell migration and invasion. In contrast, ectopic transfection of EZH2 led to reduced E‐cadherin expression and enhanced cell migration and invasion. Furthermore, EZH2 may act on cell migration in part by suppressing the E‐cadherin expression. Taken together, these data suggest that EZH2 plays major roles in the progression of OTSCC, and may serve as a biomarker or therapeutic target for patients at risk of metastasis. © 2011 Wiley Periodicals, Inc.</description><identifier>ISSN: 0899-1987</identifier><identifier>EISSN: 1098-2744</identifier><identifier>DOI: 10.1002/mc.21848</identifier><identifier>PMID: 22161744</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Biomarkers ; Cadherins - genetics ; Cadherins - metabolism ; Carcinoma, Squamous Cell - metabolism ; Carcinoma, Squamous Cell - mortality ; Carcinoma, Squamous Cell - pathology ; Cell Line, Tumor ; Cell Movement ; E-cadherin ; Enhancer of Zeste Homolog 2 Protein ; EZH2 ; Female ; Gene Expression Regulation, Neoplastic ; Humans ; Lymphatic Metastasis ; Male ; Metastasis ; Oral cancer ; Polycomb Repressive Complex 2 - genetics ; Polycomb Repressive Complex 2 - metabolism ; Prognosis ; Proteins ; squamous cell carcinoma ; Tongue Neoplasms - metabolism ; Tongue Neoplasms - mortality ; Tongue Neoplasms - pathology</subject><ispartof>Molecular carcinogenesis, 2013-03, Vol.52 (3), p.229-236</ispartof><rights>Copyright © 2011 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5428-98f91772c7ea09c4c9282010b5c8d1921c6073a17576bdf94a0fed7701ece66a3</citedby><cites>FETCH-LOGICAL-c5428-98f91772c7ea09c4c9282010b5c8d1921c6073a17576bdf94a0fed7701ece66a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmc.21848$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmc.21848$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,780,784,885,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22161744$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Cheng</creatorcontrib><creatorcontrib>Liu, Xiqiang</creatorcontrib><creatorcontrib>Chen, Zujian</creatorcontrib><creatorcontrib>Huang, Hongzhang</creatorcontrib><creatorcontrib>Jin, Yi</creatorcontrib><creatorcontrib>Kolokythas, Antonia</creatorcontrib><creatorcontrib>Wang, Anxun</creatorcontrib><creatorcontrib>Dai, Yang</creatorcontrib><creatorcontrib>Wong, David T.W.</creatorcontrib><creatorcontrib>Zhou, Xiaofeng</creatorcontrib><title>Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma</title><title>Molecular carcinogenesis</title><addtitle>Mol. Carcinog</addtitle><description>Enhancer of Zeste homolog 2 (EZH2) is a critical component of the polycomb‐repressive complex 2 (PRC2) that regulates many essential biological processes, including embryogenesis and many developmental events. The oncogenic role of EZH2 has recently been implicated in several cancer types. In this study, we first confirmed that the over‐expression of EZH2 is a frequent event in oral tongue squamous cell carcinoma (OTSCC). We further demonstrated that EZH2 over‐expression is correlated with advanced stages of the disease and is associated with lymph node metastasis. Statistical analysis revealed that EZH2 over‐expression was correlated with reduced overall survival. Furthermore, over‐expression of EZH2 was correlated with reduced expression of tumor suppressor gene E‐cadherin. These observations were confirmed in vitro, in which knockdown of EZH2‐induced E‐cadherin expression and reduced cell migration and invasion. In contrast, ectopic transfection of EZH2 led to reduced E‐cadherin expression and enhanced cell migration and invasion. Furthermore, EZH2 may act on cell migration in part by suppressing the E‐cadherin expression. Taken together, these data suggest that EZH2 plays major roles in the progression of OTSCC, and may serve as a biomarker or therapeutic target for patients at risk of metastasis. © 2011 Wiley Periodicals, Inc.</description><subject>Biomarkers</subject><subject>Cadherins - genetics</subject><subject>Cadherins - metabolism</subject><subject>Carcinoma, Squamous Cell - metabolism</subject><subject>Carcinoma, Squamous Cell - mortality</subject><subject>Carcinoma, Squamous Cell - pathology</subject><subject>Cell Line, Tumor</subject><subject>Cell Movement</subject><subject>E-cadherin</subject><subject>Enhancer of Zeste Homolog 2 Protein</subject><subject>EZH2</subject><subject>Female</subject><subject>Gene Expression Regulation, Neoplastic</subject><subject>Humans</subject><subject>Lymphatic Metastasis</subject><subject>Male</subject><subject>Metastasis</subject><subject>Oral cancer</subject><subject>Polycomb Repressive Complex 2 - genetics</subject><subject>Polycomb Repressive Complex 2 - metabolism</subject><subject>Prognosis</subject><subject>Proteins</subject><subject>squamous cell carcinoma</subject><subject>Tongue Neoplasms - metabolism</subject><subject>Tongue Neoplasms - mortality</subject><subject>Tongue Neoplasms - pathology</subject><issn>0899-1987</issn><issn>1098-2744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kV1rFDEYhYModlsFf4EEvOnN1CSTmSQ3gixrW_qhgiJ4E7KZd7apk8k0mbHuvzfbbrcqCIFcvA8P53AQekXJESWEvfX2iFHJ5RM0o0TJggnOn6IZkUoVVEmxh_ZTuiaEUlGR52iPMVrTzMzQ9Cl0axv8Eq9imAY8xDCC6_Hi-wkrPDTOjNDgRWFNcwUxHyIMEVJyod-wPtMJexhNys8lHFocounwGPrVBDjdTMaHKWELXYetidb1wZsX6FlrugQvt_8B-vph8WV-Upx_PD6dvz8vbMWZLJRsFRWCWQGGKMutYpIRSpaVlQ1VjNqaiNLkUqJeNq3ihrTQCEEoWKhrUx6gd_feYVrmMhb6MYfTQ3TexLUOxum_L7270qvwU5ecEEHLLDjcCmK4mSCN2ru06WJ6yLU0ZZIzRVi1Qd_8g16HKfa5nqac51lUrcSj0MaQUoR2F4YSvdlSe6vvtszo6z_D78CH8TJQ3AO3roP1f0X6Yv4g3PIujfBrx5v4Q9eiFJX-dnms5dnF55qdVZqVvwFHOLgg</recordid><startdate>201303</startdate><enddate>201303</enddate><creator>Wang, Cheng</creator><creator>Liu, Xiqiang</creator><creator>Chen, Zujian</creator><creator>Huang, Hongzhang</creator><creator>Jin, Yi</creator><creator>Kolokythas, Antonia</creator><creator>Wang, Anxun</creator><creator>Dai, Yang</creator><creator>Wong, David T.W.</creator><creator>Zhou, Xiaofeng</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7TO</scope><scope>8FD</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201303</creationdate><title>Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma</title><author>Wang, Cheng ; Liu, Xiqiang ; Chen, Zujian ; Huang, Hongzhang ; Jin, Yi ; Kolokythas, Antonia ; Wang, Anxun ; Dai, Yang ; Wong, David T.W. ; Zhou, Xiaofeng</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5428-98f91772c7ea09c4c9282010b5c8d1921c6073a17576bdf94a0fed7701ece66a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Biomarkers</topic><topic>Cadherins - genetics</topic><topic>Cadherins - metabolism</topic><topic>Carcinoma, Squamous Cell - metabolism</topic><topic>Carcinoma, Squamous Cell - mortality</topic><topic>Carcinoma, Squamous Cell - pathology</topic><topic>Cell Line, Tumor</topic><topic>Cell Movement</topic><topic>E-cadherin</topic><topic>Enhancer of Zeste Homolog 2 Protein</topic><topic>EZH2</topic><topic>Female</topic><topic>Gene Expression Regulation, Neoplastic</topic><topic>Humans</topic><topic>Lymphatic Metastasis</topic><topic>Male</topic><topic>Metastasis</topic><topic>Oral cancer</topic><topic>Polycomb Repressive Complex 2 - genetics</topic><topic>Polycomb Repressive Complex 2 - metabolism</topic><topic>Prognosis</topic><topic>Proteins</topic><topic>squamous cell carcinoma</topic><topic>Tongue Neoplasms - metabolism</topic><topic>Tongue Neoplasms - mortality</topic><topic>Tongue Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Cheng</creatorcontrib><creatorcontrib>Liu, Xiqiang</creatorcontrib><creatorcontrib>Chen, Zujian</creatorcontrib><creatorcontrib>Huang, Hongzhang</creatorcontrib><creatorcontrib>Jin, Yi</creatorcontrib><creatorcontrib>Kolokythas, Antonia</creatorcontrib><creatorcontrib>Wang, Anxun</creatorcontrib><creatorcontrib>Dai, Yang</creatorcontrib><creatorcontrib>Wong, David T.W.</creatorcontrib><creatorcontrib>Zhou, Xiaofeng</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Molecular carcinogenesis</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Cheng</au><au>Liu, Xiqiang</au><au>Chen, Zujian</au><au>Huang, Hongzhang</au><au>Jin, Yi</au><au>Kolokythas, Antonia</au><au>Wang, Anxun</au><au>Dai, Yang</au><au>Wong, David T.W.</au><au>Zhou, Xiaofeng</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma</atitle><jtitle>Molecular carcinogenesis</jtitle><addtitle>Mol. Carcinog</addtitle><date>2013-03</date><risdate>2013</risdate><volume>52</volume><issue>3</issue><spage>229</spage><epage>236</epage><pages>229-236</pages><issn>0899-1987</issn><eissn>1098-2744</eissn><abstract>Enhancer of Zeste homolog 2 (EZH2) is a critical component of the polycomb‐repressive complex 2 (PRC2) that regulates many essential biological processes, including embryogenesis and many developmental events. The oncogenic role of EZH2 has recently been implicated in several cancer types. In this study, we first confirmed that the over‐expression of EZH2 is a frequent event in oral tongue squamous cell carcinoma (OTSCC). We further demonstrated that EZH2 over‐expression is correlated with advanced stages of the disease and is associated with lymph node metastasis. Statistical analysis revealed that EZH2 over‐expression was correlated with reduced overall survival. Furthermore, over‐expression of EZH2 was correlated with reduced expression of tumor suppressor gene E‐cadherin. These observations were confirmed in vitro, in which knockdown of EZH2‐induced E‐cadherin expression and reduced cell migration and invasion. In contrast, ectopic transfection of EZH2 led to reduced E‐cadherin expression and enhanced cell migration and invasion. Furthermore, EZH2 may act on cell migration in part by suppressing the E‐cadherin expression. Taken together, these data suggest that EZH2 plays major roles in the progression of OTSCC, and may serve as a biomarker or therapeutic target for patients at risk of metastasis. © 2011 Wiley Periodicals, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>22161744</pmid><doi>10.1002/mc.21848</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0899-1987
ispartof Molecular carcinogenesis, 2013-03, Vol.52 (3), p.229-236
issn 0899-1987
1098-2744
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3400713
source MEDLINE; Wiley Online Library All Journals
subjects Biomarkers
Cadherins - genetics
Cadherins - metabolism
Carcinoma, Squamous Cell - metabolism
Carcinoma, Squamous Cell - mortality
Carcinoma, Squamous Cell - pathology
Cell Line, Tumor
Cell Movement
E-cadherin
Enhancer of Zeste Homolog 2 Protein
EZH2
Female
Gene Expression Regulation, Neoplastic
Humans
Lymphatic Metastasis
Male
Metastasis
Oral cancer
Polycomb Repressive Complex 2 - genetics
Polycomb Repressive Complex 2 - metabolism
Prognosis
Proteins
squamous cell carcinoma
Tongue Neoplasms - metabolism
Tongue Neoplasms - mortality
Tongue Neoplasms - pathology
title Polycomb group protein EZH2-mediated E-cadherin repression promotes metastasis of oral tongue squamous cell carcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T17%3A04%3A05IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Polycomb%20group%20protein%20EZH2-mediated%20E-cadherin%20repression%20promotes%20metastasis%20of%20oral%20tongue%20squamous%20cell%20carcinoma&rft.jtitle=Molecular%20carcinogenesis&rft.au=Wang,%20Cheng&rft.date=2013-03&rft.volume=52&rft.issue=3&rft.spage=229&rft.epage=236&rft.pages=229-236&rft.issn=0899-1987&rft.eissn=1098-2744&rft_id=info:doi/10.1002/mc.21848&rft_dat=%3Cproquest_pubme%3E3095379751%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1441099697&rft_id=info:pmid/22161744&rfr_iscdi=true